[Effects of secretory and osmotic diarrhea on rats intestinal function and morphology].
In order to compare intestinal morphology and function, diarrhea was produced in rats using laxatives in the diet. The 14 day study included two groups of rats with diarrhea (osmotic or secretory), two groups without diarrhea but with a degree of malnutrition which was similar to that seen in the rats with diarrhea (malnourished without diarrhea) and a well-nourished group (control). The inclusion of laxatives(lactose or bisoxatin acetate) cause a reduction in food intake, diarrhea an malnutrition. It also caused a reduction in dietary protein and fat digestibility which was proportional to the severity of diarrhea and more pronounced in secretory diarrhea. In the malnourished rats without diarrhea, malnutrition did not affect their absorptive function. Both in the rats with secretory and osmotic diarrhea an intestinal hypertrophy was observed. This hypertrophy was proportional to the severity of diarrhea and independent of its aetiology. In the intestines of the rats with both types of diarrhea there was inflammation, a greater number of mitotic figures but the flattening of the villi seen in the malnourished rats without diarrhea was not seen. In osmotic diarrhea there was, in addition, a patchy damage of the surface of the jejunal mucosa and an increment in the number of goblet cells, indicating a more severe intestinal deterioration. Since despite this greater deterioration, these rats absorbed more protein and fat we concluded that the alterations in intestinal morphology seen in this study was not predictive of intestinal function. The study also showed that diarrhea had a trophic effect on the intestine which did not occur in malnourished rats without diarrhea.
de Lima de Mon
Margarita
M
Escuela de Medicina Luis Razetti, Universidad Central de Venezuela (UCV), Laboratorio de Nutrición Universidad Simón Bolívar, Venezuela.
Cioccia
Anna M
AM
González
Eduardo
E
Hevia
Patricio
P
D000818:Animals; D002400:Cathartics / Q000008:administration & dosage; D003967:Diarrhea / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D004032:Diet; D004041:Dietary Fats / Q000378:metabolism; D004044:Dietary Proteins / Q000378:metabolism; D004063:Digestion; D004435:Eating; D007408:Intestinal Absorption / Q000187:drug effects; D007413:Intestinal Mucosa / Q000378:metabolism; D007421:Intestine, Small / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D007422:Intestines / Q000473:pathology* / Q000503:physiopathology*; D007785:Lactose / Q000009:adverse effects; D008297:Male; D009748:Nutrition Disorders / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D009995:Osmosis; D010078:Oxazines / Q000008:administration & dosage; D051381:Rats; D017207:Rats, Sprague-Dawley
D002400:Cathartics; D004041:Dietary Fats; D004044:Dietary Proteins; D010078:Oxazines; C030065:bisoxatin acetate; D007785:Lactose